Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
04/18/2024 12:47 PM - Business
U.S. dollar down in Taipei midday trading
04/18/2024 12:40 PM - Society
Heavy rain advisory issued for northern Taiwan
04/18/2024 12:29 PM - Business
Taiwan shares open lower
04/18/2024 10:09 AM - Business
Taiwan vanilla products recognized by international institute
04/17/2024 10:21 PM